FindTrial
Sign In

COMPARISON OF PERCEIVED STRSS, COPING AND QUALITY OF LIFE BETWEEN PATIENTS OF SOMATOFORM DISORDER AND HEALTHY CONTROLS

A COMPARATIVE STUDY OF PERCEIVED STRESS, COPING AND QUALITY OF LIFE IN PATIENTS OF SOMATOFORM DISORDER AND HEALTHY CONTROLS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/028913
Enrollment
100
Registered
2020-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F45- Somatoform disorders

Interventions

None listed

Sponsors

Dr Soumya Naskar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed patients of somatoform disorder. 2.Patients age group 18-60 years. 3.Healthy individuals in age group of 18-60 years. 4.Control group should be matched on basis of age, gender, education and economic status.

Exclusion criteria

Exclusion criteria: 1.Patients and controls having chronic mental illness, neurological illness or other psychiatric diagnosis including intellectual development disability. 2.Prior history of substance use disorder except nicotine. 3.Those who have not given written informed consent.

Design outcomes

Primary

MeasureTime frame
1.To study the perceived stress among patients with somatoform disorders and control group. 2.To study ways of coping in patients with somatoform disorder and control group. 3.To study the quality of life in patients with somatoform disorder and control group. Timepoint: 1 year—

Secondary

MeasureTime frame
To compare the stress, coping and quality of life between patients with somatoform disorder and control groupTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Soumya Naskar

Lokopriya Gopinath Bordoloi Regional Institute of Mental Health

director@lgbrimh.gov.in03712-232652

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026